GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Integer Holdings Corp (NYSE:ITGR) » Definitions » Gross Margin %

ITGR (Integer Holdings) Gross Margin % : 27.02% (As of Sep. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Integer Holdings Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Integer Holdings's Gross Profit for the three months ended in Sep. 2024 was $117 Mil. Integer Holdings's Revenue for the three months ended in Sep. 2024 was $431 Mil. Therefore, Integer Holdings's Gross Margin % for the quarter that ended in Sep. 2024 was 27.02%.

Warning Sign:

Integer Holdings Corp gross margin has been in long-term decline. The average rate of decline per year is -2.4%.


The historical rank and industry rank for Integer Holdings's Gross Margin % or its related term are showing as below:

ITGR' s Gross Margin % Range Over the Past 10 Years
Min: 26.09   Med: 28.8   Max: 33.64
Current: 26.84


During the past 13 years, the highest Gross Margin % of Integer Holdings was 33.64%. The lowest was 26.09%. And the median was 28.80%.

ITGR's Gross Margin % is ranked worse than
83.23% of 805 companies
in the Medical Devices & Instruments industry
Industry Median: 51.89 vs ITGR: 26.84

Integer Holdings had a gross margin of 27.02% for the quarter that ended in Sep. 2024 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Integer Holdings was -2.40% per year.


Integer Holdings Gross Margin % Historical Data

The historical data trend for Integer Holdings's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integer Holdings Gross Margin % Chart

Integer Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.22 26.62 27.60 26.09 26.20

Integer Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.46 26.48 26.48 27.37 27.02

Competitive Comparison of Integer Holdings's Gross Margin %

For the Medical Devices subindustry, Integer Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integer Holdings's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Integer Holdings's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Integer Holdings's Gross Margin % falls into.



Integer Holdings Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Integer Holdings's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=418.3 / 1596.673
=(Revenue - Cost of Goods Sold) / Revenue
=(1596.673 - 1178.384) / 1596.673
=26.20 %

Integer Holdings's Gross Margin for the quarter that ended in Sep. 2024 is calculated as


Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=116.6 / 431.417
=(Revenue - Cost of Goods Sold) / Revenue
=(431.417 - 314.849) / 431.417
=27.02 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Integer Holdings  (NYSE:ITGR) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Integer Holdings had a gross margin of 27.02% for the quarter that ended in Sep. 2024 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Integer Holdings Gross Margin % Related Terms

Thank you for viewing the detailed overview of Integer Holdings's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Integer Holdings Business Description

Traded in Other Exchanges
N/A
Address
5830 Granite Parkway, Suite 1150, Plano, TX, USA, 75024
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into two business segments based on the product type: medical and nonmedical. The medical segment uses the firm's technologies to produce components and finished medical devices, and it generates the vast majority of revenue. The company earns more than half of its revenue in the United States.
Executives
Jean M. Hobby director 10000 WEHRLE DRIVE, CLARENCE NY 14031
Martin C Maxwell director PARKER HANNIFIN CORPORATION, 6035 PARKLAND BLVD, CLEVELAND OH 44124
John A Harris officer: VP, Operations Cardio & Vascul 10000 WEHRLE DRIVE, CLARENCE NY 14031
James F. Hinrichs director 3750 TORREY VIEW COURT, SAN DIEGO CA 92130
Payman Khales officer: President, C&V 10000 WEHRLE DRIVE, CLARENCE NY 14031
Andrew Senn officer: SVP, Strategy and Business Dev 5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Tommy P Thomas officer: VP, Corporate Controller 10000 WEHRLE DRIVE, CLARENCE NY 14031
Donald J Spence director C/O OAKMONT ACQUISITION CORP., 33 BLOOMFIELD HILLS PARKWAY, SUITE 240, BLOOMFIELD HILLS MI 48304
Jim Stephens officer: President, CRM & Neuro 5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Diron Smith officer: VP, Interim CFO 5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Joseph W Dziedzic director 1801 BAYBERRY COURT, RICHMOND VA 23226
Pamela G Bailey director 1200 G ST NW, STE 400, WASHINGTON DC 20005-3814
Jennifer M Bolt officer: President, Electrochem 10000 WEHRLE DRIVE, CLARENCE NY 14031
Carter Houghton officer: President, Electrochem 10000 WEHRLE DRIVE, CLARENCE NY 14031
Marshall Mcalister C Ii officer: SVP, Gen Counsel & Secretary 1801 BAYBERRY COURT, P.O. BOX 18100, RICHMOND VA 23226